ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

HUMA Humacyte Inc

4.61
-0.07 (-1.50%)
11 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Humacyte Inc NASDAQ:HUMA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.07 -1.50% 4.61 4.60 4.62 4.63 4.41 4.60 2,729,230 00:38:47

Humacyte, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - HUMA

02/01/2025 3:07pm

PR Newswire (US)


Humacyte (NASDAQ:HUMA)
Historical Stock Chart


From Dec 2024 to Jan 2025

Click Here for more Humacyte Charts.

LOS ANGELES, Jan. 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Humacyte, Inc. ("HUMA" or "the Company") (NASDAQ: HUMA) for violations of the federal securities laws.

DJS Law Group

Shareholders who bought the Company's securities between May 10, 2024, and October 17, 2024, inclusive (the "Class Period"), are encouraged to contact DJS Law Group before January 17, 2025.

CASE DETAILS: According to the Complaint, Humacyte allegedly made false statements regarding it failure to maintain good manufacturing practices including with its microbial testing at its Durham, North Carolina facility. The FDA's review of the Company's Biologic License Application (BLA) would be delayed while it fixed its manufacturing problems.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
 Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/humacyte-inc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--huma-302341058.html

SOURCE DJS Law Group LLP

Copyright 2025 PR Newswire

1 Year Humacyte Chart

1 Year Humacyte Chart

1 Month Humacyte Chart

1 Month Humacyte Chart

Your Recent History

Delayed Upgrade Clock